journal article·2026-02Open access

ETV1 Drives CD4 + T Cell‐Mediated Intestinal Inflammation in Inflammatory Bowel Disease Through Amino Acid Transporter Slc7a5

Yan Shi, Song Wang, Yuqing Yan, Wei Chen, Yingying Cao, Dafan Chen, Wei Chen, Caiyun Ma, Xinjian Wan

Advanced Science· Volume 13· Issue 11

Abstract

Abstract Excessive CD4 + T cell responses drive inflammatory bowel disease (IBD), yet the transcriptional mechanisms underlying their dysfunction remain incompletely understood. Here, it is demonstrated that E‐twenty‐six variant transcription factor 1 (ETV1) is upregulated in IBD patients and positively correlates with disease severity. Etv1 deficiency impairs CD4 + T cell activation, proliferation, and T helper 17 (Th17) cell differentiation, thereby ameliorating TNBS‐induced colitis. Moreover, Etv1 deficiency attenuates CD45RB high CD4 + T cell‐induced colitis, characterized by a reduction in pathogenic CD4 + T cells in the intestinal mucosa. Pharmacological inhibition of ETV1 ameliorates colitis in recombination activating gene 1‐deficient mice and suppresses human IBD T cell responses ex vivo. Mechanistically, Etv1 binds to the promoter of the gene encoding the amino acid transporter solute carrier family 7 member 5 (Slc7a5), enhancing its expression and subsequent amino acid uptake to fuel T cell pathogenicity. Restoring Slc7a5 expression rescues the proliferation, differentiation, and colitogenic function of Etv1‐deficient CD4⁺ T cells. Clinically, SLC7A5 is upregulated in IBD, and its blockade ameliorates T cell‐driven colitis in vivo. Collectively, the results establish a critical role for the ETV1‐Slc7a5 axis in driving pathogenic CD4⁺ T cell responses in IBD, highlighting this pathway as a novel therapeutic target.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Amino Acid Enzymes and Metabolism · Gut microbiota and health · Inflammatory Bowel Disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Digestive Endoscopic Center Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai 200233 China

Department of Gastroenterology Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai 200233 China

Department of Gastroenterology The Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai 200072 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shanghai Municipality · Shanghai Municipal Health Commission

References (43)

Show source-provided references
1. 10.1136/gutjnl-2024-33401010.1136/gutjnl-2024-334010 ↗
2. 10.1016/j.mucimm.2024.03.01010.1016/j.mucimm.2024.03.010 ↗
3. 10.1038/s41575-023-00871-310.1038/s41575-023-00871-3 ↗
4. 10.1186/s40364-024-00612-x10.1186/s40364-024-00612-x ↗
5. Yan Y. · J. Crohn's colitis · 2025 · 19 · 3
6. 10.1016/j.cytogfr.2022.07.00510.1016/j.cytogfr.2022.07.005 ↗
7. 10.1038/s41590-022-01387-910.1038/s41590-022-01387-9 ↗
8. 10.1016/j.jaut.2022.10287210.1016/j.jaut.2022.102872 ↗
9. 10.1038/s41423-024-01218-x10.1038/s41423-024-01218-x ↗
10. 10.1080/19490976.2025.256001910.1080/19490976.2025.2560019 ↗
11. 10.1084/jem.2019061310.1084/jem.20190613 ↗
12. 10.7554/eLife.5372510.7554/eLife.53725 ↗
13. 10.1016/j.jaut.2023.10303110.1016/j.jaut.2023.103031 ↗
14. 10.1016/j.jaci.2019.09.02510.1016/j.jaci.2019.09.025 ↗
15. 10.1073/pnas.222135212010.1073/pnas.2221352120 ↗
16. 10.1038/s12276-024-01286-z10.1038/s12276-024-01286-z ↗
17. 10.1136/jitc-2024-01089010.1136/jitc-2024-010890 ↗
18. Zhang T. · J. Exp. Clin. Cancer Res., CR · 2022 · 41 · 275
19. 10.1038/s41422-023-00802-610.1038/s41422-023-00802-6 ↗
20. 10.1161/CIRCULATIONAHA.120.04812110.1161/CIRCULATIONAHA.120.048121 ↗
21. 10.2991/978-94-6463-780-910.2991/978-94-6463-780-9 ↗
22. 10.1158/1535-7163.MCT-13-068910.1158/1535-7163.MCT-13-0689 ↗
23. 10.1038/s41591-023-02556-510.1038/s41591-023-02556-5 ↗
24. 10.1159/00044513310.1159/000445133 ↗
25. 10.1096/fj.202301127RR10.1096/fj.202301127RR ↗
26. 10.3389/fimmu.2022.105591410.3389/fimmu.2022.1055914 ↗
27. 10.1093/ibd/izac19910.1093/ibd/izac199 ↗
28. 10.1016/j.immuni.2018.09.00410.1016/j.immuni.2018.09.004 ↗
29. 10.1084/jem.2021244310.1084/jem.20212443 ↗
30. 10.1016/j.celrep.2016.05.08810.1016/j.celrep.2016.05.088 ↗
31. 10.1016/j.intimp.2020.10618710.1016/j.intimp.2020.106187 ↗
32. 10.1073/pnas.141896611110.1073/pnas.1418966111 ↗
33. 10.1038/s41586-022-05264-110.1038/s41586-022-05264-1 ↗
34. 10.1016/j.cell.2021.06.00710.1016/j.cell.2021.06.007 ↗
35. 10.1007/s00281-022-00959-z10.1007/s00281-022-00959-z ↗
36. 10.1016/j.jaci.2025.07.01810.1016/j.jaci.2025.07.018 ↗
37. 10.1016/j.immuni.2021.04.01410.1016/j.immuni.2021.04.014 ↗
38. 10.1016/j.celrep.2024.11399510.1016/j.celrep.2024.113995 ↗
39. 10.1111/all.1401910.1111/all.14019 ↗
40. 10.1016/j.intimp.2022.10881710.1016/j.intimp.2022.108817 ↗
41. 10.1016/j.jconrel.2023.08.05910.1016/j.jconrel.2023.08.059 ↗
42. 10.1111/all.1579810.1111/all.15798 ↗
43. 10.1007/s10637-020-00924-310.1007/s10637-020-00924-3 ↗